Get ready to walk in one of the largest events to help put an end to Alzheimer's. The Alzheimer's Association is calling on ...

In this GEN webinar, our expert speaker, Dr. Sterling Johnson, will discuss multi-plex blood biomarker assays, new discoveries in AD research from a large-scale study, and opportunities for early ...

Alzheimer's disease is a neurological condition that gradually impairs thinking and memory abilities. Nearly 7 million ...

The European Medicines Agency’s human medicines committee is re-examining the marketing authorisation application for the ...

Weill Cornell Medicine investigators have found that two genetic variants that confer high risk of Alzheimer's disease (AD) ...

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

There is more hope than ever surrounding the diagnosis and treatment of dementia. Take care of your brain health and talk to ...

While Alzheimer's disease is irreversible, a plant-based diet has a huge role to play in its prevention and delaying its ...

Discovery may offer new therapeutic target for development of new drugs against Alzheimer's and other neurodegenerative disorders.

The company aims to streamline its own lab operations while also enabling distribution of its Alzheimer's tests to outside labs both in the US and abroad.

On Saturday, Sept. 21, the annual Rocky Mountain Alzheimer’s Walk was held in Eagle. Every year, the event is gaining in ...